XML 39 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
3 Months Ended 6 Months Ended 0 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended 6 Months Ended 5 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Dec. 28, 2012
Dec. 30, 2011
Dec. 28, 2012
Dec. 30, 2011
Dec. 28, 2012
Stock options
Dec. 28, 2012
Stock options
Dec. 30, 2011
Stock options
Dec. 28, 2012
Restricted stock units (RSUs)
Dec. 28, 2012
Restricted stock units (RSUs)
Dec. 30, 2011
Restricted stock units (RSUs)
Dec. 28, 2012
Restricted stock units (RSUs)
Dec. 30, 2011
Restricted stock units (RSUs)
Dec. 28, 2012
Executive PSUs
Dec. 28, 2012
Option Plan
Dec. 30, 2011
Option Plan
Dec. 28, 2012
Option Plan
Dec. 30, 2011
Option Plan
Aug. 31, 2012
Equity Incentive Plan - 2005
Restricted stock units (RSUs)
Executive
Aug. 31, 2012
Equity Incentive Plan - 2005
Executive PSUs
Executive
Intstallment
Dec. 28, 2012
Employee Stock Purchase Plan - 2005
Dec. 30, 2011
Employee Stock Purchase Plan - 2005
Dec. 28, 2012
Employee Stock Purchase Plan - 2005
Dec. 30, 2011
Employee Stock Purchase Plan - 2005
Dec. 28, 2012
Employee Stock Purchase Plan - 2005
Employee Stock
Dec. 28, 2012
Cost of revenue
Dec. 30, 2011
Cost of revenue
Dec. 28, 2012
Cost of revenue
Dec. 30, 2011
Cost of revenue
Dec. 28, 2012
Research and development
Dec. 30, 2011
Research and development
Dec. 28, 2012
Research and development
Dec. 30, 2011
Research and development
Dec. 28, 2012
Sales and marketing
Dec. 30, 2011
Sales and marketing
Dec. 28, 2012
Sales and marketing
Dec. 30, 2011
Sales and marketing
Dec. 28, 2012
General and administrative
Dec. 30, 2011
General and administrative
Dec. 28, 2012
General and administrative
Dec. 30, 2011
General and administrative
Share-based compensation:                                                                                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period                                   4 years                                            
Share-based compensation expense $ 2,496,000 $ 2,240,000 $ 5,007,000 $ 4,309,000                                         $ 371,000 $ 385,000 $ 871,000 $ 667,000 $ 588,000 $ 507,000 $ 1,127,000 $ 1,022,000 $ 423,000 $ 439,000 $ 809,000 $ 800,000 $ 1,114,000 $ 909,000 $ 2,200,000 $ 1,820,000
Weighted average fair value assumptions:                                                                                
Risk-free interest rate                           0.70% 0.80% 0.70% 1.10%     0.20% 0.10% 0.20% 0.10%                                  
Volatility                           67.60% 65.00% 67.60% 74.30%     83.00% 80.00% 83.00% 80.00%                                  
Weighted average expected life                           5 years 4 years 5 months 16 days 5 years 4 years 7 months 21 days     1 year 3 months 1 year 3 months 1 year 3 months 1 year 3 months                                  
Expected dividend yield                           0.00% 0.00% 0.00% 0.00%     0.00% 0.00% 0.00% 0.00%                                  
Weighted average fair value (USD per share)                           $ 3.67 $ 6.15 $ 3,670.00 $ 8,340.00     $ 4.39 $ 6.43 $ 4,390.00 $ 6,430.00                                  
Options outstanding, shares:                                                                                
Options outstanding, beginning of period (in shares)     3,703,660                                                                          
Options granted (in shares)     64,000                                                                          
Options exercised (in shares)     (144,190)                                                                          
Options cancelled (in shares)     (207,754)                                                                          
Options outstanding, end of period (in shares) 3,415,716   3,415,716                                                                          
Vested and expected to vest (in shares) 3,237,345   3,237,345                                                                          
Exercisable (in shares) 2,365,234   2,365,234                                                                          
Options outstanding, weighted average exercise price:                                                                                
Options outstanding, beginning balance, weighted average exercise price (USD per share)     $ 10.79                                                                          
Options granted, weighted average exercise price (USD per share)     $ 6.62                                                                          
Options exercised, weighted average exercise price (USD per shares)     $ 5.36                                                                          
Options cancelled, weighted average exercise price (USD per share)     $ 12.36                                                                          
Options outstanding, ending balance, weighted average exercise price (USD per share) $ 10.84   $ 10.84                                                                          
Vested and expected to vest, weighted average exercise price (USD per share) $ 10.88   $ 10.88                                                                          
Exercisable, weighted average exercise price (USD per share) $ 11.28   $ 11.28                                                                          
Options outstanding, weighted average remaining contractual term     5 years 3 months 11 days                                                                          
Vested and expected to vest, weighted average remaining contractual term     5 years 0 months 29 days                                                                          
Exercisable, weighted average remaining contractual term     3 years 9 months 15 days                                                                          
Options outstanding, aggregate intrinsic value 4,787,000   4,787,000                                                                          
Vested and expected to vest, aggregate intrinsic value 4,498,000   4,498,000                                                                          
Exercisable, aggregate intrinsic value 3,146,000   3,146,000                                                                          
Total intrinsic value of options exercised in period           400,000 900,000                                                                  
Total fair value of shares vested during period           2,100,000 1,400,000                                                                  
Total unrecognized compensation cost related to non-vested awards, options         2,300,000 2,300,000                                                                    
Total compensation cost related to non-vested awards, period for recognition         1 year 2 months 16 days     2 years 11 months 3 days                                                                
Restricted stock activity, number of shares:                                                                                
Equity instruments other than options, outstanding, beginning of period (in shares)                     918,764                                                          
Equity instruments other than options, awarded (in shares)                     785,489   231,000                                                      
Equity instruments other than options, released (in shares)                     (131,942)                                                          
Equity instruments other than options, forfeited (in shares)                     (112,001)                                                          
Equity instruments other than options, outstanding, end of period (in shares)               1,460,310 1,460,310   1,460,310                                                          
Equity instruments other than options, vested and expected to vest (in shares)               1,110,747 1,110,747   1,110,747                                                          
Initial vesting percentage                                   25.00% 25.00%                                          
Duration of annual vesting                                   1 year                                            
Quarterly vesting percentage                                   6.25%                                            
Remaining vesting percentage                                     75.00%                                          
Number of annual vesting installments                                     3                                          
Shares withheld for taxes                 22,764 27,665 47,145,000 57,031,000                                                        
Amounts withheld for taxes     379,000 799,000         188,000 397,000 375,000 818,000                                                        
Total unrecognized compensation cost related to non-vested awards, equity instruments other than options               $ 8,200,000 $ 8,200,000   $ 8,200,000                         $ 1,600,000                                
Equity instruments other than options, vested and expected to vest, weighted average remaining contractual term                                               1 year 7 months 12 days                                
Employee Stock Purchase Plan:                                                                                
Shares issued (in shares)     256,972 259,347                                                                        
Weighted-average purchase price per share (USD per share)     $ 6.76 $ 5.99